At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
In the news
5 articles- #ADA26: 19% of Phase 3 patients quit Boehringer obesity shot over side effectsEndpoints News·2026-06-07
- Innovent declares Phase 3 success for ADC that attracted huge Takeda dealEndpoints News·2026-06-05
- Otsuka energizes IgA neuropathy space with new Phase 3 Voyxact dataBioSpace·2026-06-05
- <a href="https://www.fiercebiotech.com/biotech/parabilis-preps-413m-ipo-fuel-desmoid-tumor-drug-phase-3" hreflang="en">Parabilis preps $413M IPO to fuel desmoid tumor drug into phase 3</a>FierceBiotech
- <a href="https://www.fiercebiotech.com/biotech/innovent-fresh-12b-deal-posts-phase-3-win-cldn182-adc" hreflang="en">Innovent, fresh from $1.2B deal, posts phase 3 win for Takeda-partnered ADC</a>FierceBiotech
Matched to this trial by ClinicalIndexfrom reputable biotech & medical press.
Healthy Weights for Children Project (Phase 3)
In Brief
A clinical study evaluating Healthy Together for Health Knowledge, Attitudes, Practice and Overweight and Obesity. Completed, enrolled 3,400 participants across 1 site.
Detailed Summary
Healthy Together is a program that promotes the achievement and maintenance of healthy weights in children and their families.
Study Details
Timeline
Interventions
The Healthy Together (HT) program is designed to reduce overweight and obesity among children and youth in priority populations such as Indigenous, immigrant and refugee, and low income families.The HT program consists of 30 sessions, each of which includes cooking and eating together, physical activity and a learning activity covering topics that promote healthy weights. The HT program is delivered by trained facilitators who are provided with a program manual and resources. Trained facilitators in participating community organizations offer the HT program by integrating it within core programming.